P19. Immunomodulation of blasts in AML-patients (pts) with clinically approved response modifiers to improve anti leukaemic T-cell reactivity: an ex vivo simulation of the clinical...

por Schmetzer, H, Stankova, Z, Deen, D, Hirn, A, Vokac, Y, Kroell, T, Buhmann, R, Hausmann, A, Schmid, C, Tischer, J
Publicado 2014